1 of 1
Story summary
- GLP-1 medications, such as semaglutide and tirzepatide, improve weight management and diabetes care by regulating appetite.
- Public figures, including Serena Williams, support these drugs for their significant weight loss benefits.
- Over 12% of U.S. adults have used GLP-1s, but high costs limit access.
- Long-term use is essential for sustained weight loss, as many regain weight after discontinuation.
- The U.S. obesity rate has reached 42%, emphasizing the demand for effective solutions.
